Atherosclerosis and lipid lowering drugs Flashcards

1
Q

what do the apoproteins define?

A

the type of lipoprotein
A-1: HDL
B: LDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe the exogenous pathway of lipid metabolism

A
  • when we eat food, it is broken down into chylomicrons (large)
  • which are broken down into FFAs and chylomicron remnants
  • remnants deposit in vessels
  • atheroma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe the endogenous pathway

A
  • most LDL/HDL comes from this
  • lipoprotein lipase and hepatic lipase metabolise most
  • HDLs and LDLs are deposited in vessels to form atheromas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is reverse cholesterol transport?

A

removal of cholesterol from vessel walls back to liver by HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define atherosclerosis

A

inflammatory fibro-proliferative disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe the steps to atherosclerosis

A
  1. LDL enters endothelium into tunica intima
  2. LDLs are oxisided by macrophages and VSMCs
  3. release of GF and cytokines
  4. additional monocytes/macrophages recruited
  5. Foam cell accumulation
  6. VSMC migration
  7. VSMC proliferation
  8. plaque growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is in the tunica media?

A

VSMCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe the endothelial dysfunction in atherosclerosis

A
  • inc. endothelial permeability
  • upregulation of adhesion molecules
  • leucocyte adhesion
  • migration of leucocytes into artery wall
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the fatty streak formation

A
  • migration of VSMCs
  • activation of T cells
  • adherence and activation of platelets
  • formation of foam cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe complicated plaque formation

A
  • formation of fibrous cap
  • accumulation of macrophages
  • formation of necrotic core
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe what is seen in the different lesions in atherosclerosis

A
  1. lesion-prone location = adaptive thickening
  2. type 2 lesion = foam cells
  3. type 3 lesion (preatheroma) = extracellular lipid
  4. type 4 lesion (atheroma) = bigger core of extracellular lipid
  5. type 5 lesion (fibroatheroma) = fibrous thickening
  6. type 6 lesion (complicated lesion) = fissure and haematoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the remnant lipids?

A
chylomicron remnants that are very good at infiltrating endothelial wall
remnants include:
- VLDL
- CM remnants
- IDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the inflammatory part of atherosclerosis caused by?

A

lipid remnants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe a stable plauque

A
  • thick fibrous cap
  • thinner lumen
  • less likely to rupture
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe an unstable plaque

A
  • thin fibrous cap
  • rich core of lipids and macrophages
  • less evidence of VSMC proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are LDLs associated with? what are these events modified by?

A

associated w/ atherosclerosis and CHD events
10% inc. in LDL –> 20% inc. in CHD events
events modified by: smoking, low HDL, hypertension, diabetes

17
Q

what is HDL? what is HDL lowered by?

A
  • protective effect for atherosclerosis and CHD events
  • HDL tends to be low when TG are high
  • HDL lowered by smoking, obesity, physical inactivity
18
Q

what are the 3 different drug therapies used in the past?

A
  • bile acid sequestrants - poor compliance
  • nicotinic acid (inc. HDL well but SEs)
  • statins (1st line treatment for dyslipidaemia, highly effective at lowering LDL)
19
Q

what is the MoA of statins?

A

HMG-CoA reductase inhibitors

  • halts cholesterol synthesis pathway at RLS
  • reduces modification of proteins involved in modifying gene translation to create LDL
20
Q

what effect do statins have on the LDL receptors?

A
  • up regulate the LDL receptors expressed on hepatocytes in liver
  • results in more LDL being removed from blood
  • results in more HDL levels
21
Q

what is the selectivity ratio?

A
  • higher selectivity ratio, greater the chance of it being concentrated in hepatocyte
    e.g. Simvastatin = 0.54, Pravastatin = 3.3
    simvastatin gets into many cells as is very lipid soluble, pravastatin mainly hepatocytes
22
Q

what is potency?

A

lower the number, the more powerful the drug is as an inhibitor of enzyme

23
Q

which statin has the greatest effect in reducing LDL and raising HDL?

A

Rosuvastatin

but just has a modest effect in reducing TG

24
Q

what is the rule of 6?

A

doubling the dose ONLY makes a 6% extra reduction

25
Q

what happens when LDLs are lowered too much?

A

problems in CNS and memory

26
Q

what is the MoA of fibrates?

A

PPAR-alpha receptor agonist
PPAR (peroxisome proliferator activated receptors)
act on liver
dec. FFAs and TGs
inc. HDL very well but LDL doesn’t change a lot

27
Q

what does Ezetimibe do?

A
  • inhibits cholesterol absorption

- ezetimibe –> glucuronide in intestines = ACTIVATED

28
Q

what can Ezetimibe be coadministered with?

A

statins to avoid rule of 6

statins have more dramatic effect at lowering LDL

29
Q

what do cholesterol ester transfer protein (CETP) inhibitors do?

A
  • CETP converts HDL into LDL
  • inhibiting it causes inc. HDL
  • but their use lead to a lot of unexpected deaths so use discontinued
30
Q

What is PCSK9?

A
  • inhibitor of LDL receptor
  • monoclonal anti-PCSK9 antibodies inactivate PCSK9 so more LDL can be absorbed by lower
  • people with familial hypercholesterolemia benefit well